Acute liver failure leads to hepatic encephalopathy.
急性肝功能衰竭可导致肝性脑病。
This article discusses on the pathogenesis of hepatic encephalopathy.
本文就对肝性脑病的发病机制进行综述。
Treatment options and goals depend on the acuity of hepatic encephalopathy.
治疗方法的选择及目的依据肝性脑病的程度而定。
Neurocognitive impairment in liver patients is called hepatic encephalopathy.
肝硬化患者中的神经认知障碍被称为肝性脑病。
Objective To observe the efficacy of coenzyme complex in treating hepatic encephalopathy.
目的观察复合辅酶治疗肝性脑病的临床疗效。
Objective: To discuss predisposing causes of hepatic encephalopathy and nursing for the patient.
目的：探讨肝性脑病的诱因及护理措施。
Methods The clinical data of 48 cases with hepatic encephalopathy in this hospital were reviewed.
方法48例肝性脑病患者的临床资料进行回顾性分析。
Methods The MRI findings of 18 patients with hepatic encephalopathy were retrospectively analyzed.
方法：对临床确诊的18例肝性脑病患者的MRI表现进行回顾性分析。
Objective To observe the effect of naloxone on cirrhotic patients with hepatic encephalopathy (HE).
目的观察纳洛酮治疗肝硬化合并肝性脑病的疗效。
Objective To investigate the relation between precipitating factors and prognosis of hepatic encephalopathy.
目的探讨肝性脑病的诱因与预后的关系。
The present invention discloses one kind of medicine for treating hepatic diseases and hepatic encephalopathy.
本发明公开了一种治疗肝病及其所伴肝性脑病的药物。
Objective: To evaluate the effect and safety of L-ornithine-L-aspartate on Subclinical Hepatic Encephalopathy.
目的：观察门冬氨酸鸟氨酸治疗亚临床肝性脑病的临床疗效及安全性。
Objective To investigate the prevalence of subclinical hepatic encephalopathy (SHE) in patients with cirrhosis.
目的前瞻性调查肝硬化患者的亚临床肝性脑病(SHE)的发病情况。
Hepatic encephalopathy is a serious liver disease caused by a metabolic disorder of the neural basis of mental syndrome.
肝性脑病是各种严重肝脏疾病所致的以代谢紊乱为基础的神经、精神综合征。
AIM to evaluate the diagnostic value of evoked potentials (ep) in subclinical hepatic encephalopathy due to liver cirrhosis.
目的：探讨神经诱发电位对肝硬化亚临床脑病的诊断价值。
Conclusions:Patients with"ex-liver"pattern of portal vein flow after TIPSS are more likely to develop hepatic encephalopathy.
结论：TIPSS术后门静脉血流方向呈离肝型者容易发生肝性脑病；
Objective To observe the therapeutic effects of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy.
目的观察左旋门冬氨酸-鸟氨酸治疗肝硬化合并肝性脑病的临床疗效。
Objective: To investigate the alkalosis and hypoxemia in patients with liver cirrhosis accompanied by hepatic encephalopathy (he).
目的：探讨肝硬化患者并发肝性脑病(HE)时的碱中毒与低氧血症。
Objective To evaluate the clinical efficacy and safety of L-ornithine-L-aspartate treating the patients with hepatic encephalopathy.
目的 应用门冬氨酸鸟氨酸对肝性脑病的临床疗效及安全性进行观察。
Objective To investigate the effects of "Qingkai Granule" on neural evoked potential in subclinical hepatic encephalopathy(SHE) rats.
目的探讨清开颗粒对亚临床肝性脑病（SHE）大鼠神经诱发电位的影响。
Conclusion Naloxone and ornithine aspartate in the treatment of the liver cirrhosis and hepatic encephalopathy was exactly effective.
结论纳洛酮联合门冬氨酸鸟氨酸治疗肝性脑病疗效确切。
Objective To explore the imbalance of the intestinal flora on ammonia concentrations in experimental rats with hepatic encephalopathy.
目的探讨肝性脑病实验大鼠肠道菌群失调对血氨浓度的影响。
Objective To observe the clinical efficacy of lactulose in different courses for patients with subclinical hepatic encephalopathy (SHE).
目的观察乳果糖对亚临床肝性脑病(SHE)不同疗程的疗效。
To explore the clinical effectiveness of naloxone and ornithine aspartate in the treatment of the liver cirrhosis and hepatic encephalopathy.
探讨纳洛酮联合门冬氨酸鸟氨酸治疗肝硬化并肝性脑病患者的临床疗效。
Objective:To study the relationship between free radical and hepatic encephalopathy after TIPSS by examing MDA in hepatic tissue and SOD in blood.
目的：测定TIPSS前后犬肝组织丙二醛（MDA）和犬静脉血超氧化物歧化酶（SOD）的变化，分析TIPSS术后氧自由基变化与肝性脑病的关系。
Conclusions the changes of the amino acid receptor gated ion channel currents play an important role in the pathogenesis of hepatic encephalopathy.
结论氨基酸受体门控性离子通道电流改变在肝性脑病发生中起一定作用。
Surgical thrombectomy is not preferred as treatment method for PVT since it is invasive, technically difficult and can cause hepatic encephalopathy.
对于PVT的治疗外科血栓切除术不是首选治疗方法，因为它具有侵入性，技术上存在困难并且易引起肝性脑病。
This text summarized the epidemiologic and pathobiologic feature of subclinical hepatic encephalopathy, and reviewed the advancement of neuropsychol…
本文总结了亚临床肝性脑病的流行病学及病理特点，并综述了近些年神经心理学检测的研究进展。
CONCLUSION ep measurement seems to be a sensible and objective method for the evaluation of subclinical hepatic encephalopathy due to liver cirrhosis.
结论：诱发电位检查对于肝硬化亚临床肝性脑病是一种客观而又敏感的方法。
CONCLUSION ep measurement seems to be a sensible and objective method for the evaluation of subclinical hepatic encephalopathy due to liver cirrhosis.
结论：诱发电位检查对于肝硬化亚临床肝性脑病是一种客观而又敏感的方法。
应用推荐